Translational Session
Throw It into Reverse: AKI Science at the Bedside
November 04, 2022 | 10:30 AM - 12:30 PM
Location: W320 Chapin, Orange County Convention Center, West Building
Session Description
This session explores the exciting results emerging from a bedside-first approach to AKI discovery research. Particular emphasis is placed on novel tools and technologies, surprising results from clinical trials, and establishing partnerships across traditional silos of research to accelerate progress in AKI research.
Learning Objective(s)
- Identify how novel technologies are enabling cutting-edge interrogation of kidneys
- Describe how lessons from precision medicine in oncology are being applied in AKI research
- Discuss how SGLT2 inhibition may be changing how we think about AKI pathogenesis
Learning Pathway(s)
- AKI and Critical Care
- Onconephrology
Moderators
- Eryn E. Dixon, PhD
- Joachim H. Ix, MD, FASN
Presentations
- Updates from the Kidney Precision Medicine Project
10:30 AM - 11:00 AM
Jonathan Himmelfarb, MD, FASN
- Mechanistic Markers Have Transformed Oncology, So What's on the Horizon for AKI?
11:00 AM - 11:30 AM
Shruti Gupta, MD, MPH
- SGLT2 Inhibitors and AKI Protection: Signal, Noise, So What?
11:30 AM - 12:00 PM
Sarah C. Huen, MD, PhD
- Advances in Imaging to Assess Kidney Health and Reserve
12:00 PM - 12:30 PM
Anand Srivastava, MD, MPH
